Search

everythinglearnresearchcommunity

for

Search:↓

A stable and simple finasteride suspension was developed that retains over 94.3% of its concentration for up to 90 days and doesn't significantly increase occupational exposure, but safety measures are still advised.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

Minoxidil in Espumil foam stays stable for at least 90 days at room temperature.

Topical glycopyrrolate lotion helped reduce excessive sweating from eating in a diabetic man.

Glycine reduces skin pigmentation by lowering melanin production.

Minoxidil in FOAMIL is stable for at least 180 days at various concentrations.

Escitalopram might effectively treat delusions of parasitosis and possibly Morgellons disease, with psychological factors being important to consider.

A method was developed to test the breakdown of Finasteride capsules, showing it can tell the difference between different brands and highlighting the need for standard tests and ingredient consistency.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

The document concludes that mesotherapy can be effective for skin and hair treatments, but more research is needed to confirm its safety and effectiveness.

PRP can reduce pain and improve function, but more standardized research is needed.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

S100A3 protein is crucial for hair shaft formation in mice.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Avoiding certain fragrances improved the man's skin condition.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Alopecia greatly lowers the quality of life for South African Black women, especially affecting their self-image and social interactions.